ESTINT: Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia

Sponsor
University of Sao Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT01664884
Collaborator
(none)
120
1
7
17.1

Study Details

Study Description

Brief Summary

The aim of this study is to explore the levels of internalized stigma in a sample of young patients with bipolar disorder or schizophrenia.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The stigma is considered by patients, government organizations and health professionals a key point in mental illness (Griffiths et al, 2006). The related literature has focused on individuals with schizophrenia although there are indications that stigma act negatively in patients with bipolar disorder; this, in turn, is described in a few studies, always with heterogeneous samples, chronic and symptomatic patients (Perlick et al, 2001). It is also known that there is a significant association between affective symptoms and the presence of stigma, (Vázquez et al, 2010).

    There are reports of higher levels of public stigma towards people with schizophrenia, compared to patients with bipolar disorder or unipolar depression, however there are no studies available on internalized stigma in such samples, especially in remitted patients . Since schizophrenia coexists with significant impairment of insight, such individuals may exhibit more difficulty internalizing the external bias and stereotypes. On the other hand, patients with bipolar disorder - despite being less discriminated by the public in relation to schizophrenia - probably have a high potential for self-stigma and its fearsome consequences, justified by higher levels of insight.

    The investigators would like to examine whether the lower impairment of insight in young bipolar patients(in relation to young people with schizophrenia) could be accompanied by an increase in internalized stigma in this sample. It´s an observational, cross-sectional study with no intervention.

    Hypothesis: the internalized stigma in young adults with bipolar disorder is identical to that of young patients with schizophrenia.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    120 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Internalized Stigma in a Sample of Young Adults With Bipolar Disorder or Schizophrenia.
    Study Start Date :
    Jun 1, 2012
    Anticipated Primary Completion Date :
    Jan 1, 2013
    Anticipated Study Completion Date :
    Jan 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Bipolar Disorder Patients

    Bipolar Disorder Patients, with age between 18 to 40 years old, at euthymic phase.

    Schizophrenia Patients

    Schizophrenia Patients, with age between 18 to 40 years old, with minimum or none positive symptoms.

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 40 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Diagnosis of bipolar disorder and schizophrenia according to DSM-IV-TR, presenting in euthymia (bipolar disorder) or without positive symptoms (schizophrenia), based on clinical assessment and confirmed by structured clinical interview SCID-P

      • Age between 18 and 40 years

      • Literate and able to understand the tasks required.

      • Residents of Greater Sao Paulo.

      • Patients and / or legal representatives must understand the nature of the study and sign an informed consent.

      Exclusion Criteria:
      • Patients with Schizoaffective Disorder or Mental Retardation.

      • Unstable serious diseases including kidney disease, gastroenterology, respiratory, cardiovascular, endocrine, neurological, immunological or haematological.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 PROGRUDA-Institute of Psychiatry- HCFMUSP Sao Paulo SP Brazil

      Sponsors and Collaborators

      • University of Sao Paulo

      Investigators

      • Study Director: Ricardo Alberto Moreno, MD PhD, University of Sao Paulo

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Ricardo Alberto Moreno, M.D., Ph.D., Ricardo Alberto Moreno, University of Sao Paulo
      ClinicalTrials.gov Identifier:
      NCT01664884
      Other Study ID Numbers:
      • ESTINT
      First Posted:
      Aug 14, 2012
      Last Update Posted:
      Aug 16, 2012
      Last Verified:
      Aug 1, 2012
      Keywords provided by Ricardo Alberto Moreno, M.D., Ph.D., Ricardo Alberto Moreno, University of Sao Paulo
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Aug 16, 2012